The Association of Clinical Research Professionals

Responsible, Human-Centered AI: The Future of Clinical Research Roles

Artificial intelligence is reshaping how clinical research is planned, conducted, and overseen—and its greatest impact may be on the people and roles behind the work.

This interactive discussion delivered a practical, human-centered look at responsible AI adoption in clinical research and what it means for today’s workforce. Panelists explored why integrating AI required rethinking workflows, decision-making processes, and ethical safeguards—not simply adding technology to existing models of work.

The speakers shared their experiences on where human judgment remained essential and how organizations were approaching bias, regulatory alignment, and responsible innovation. They also illustrated how AI-enabled patient trial matching challenged traditional site activation models, shifted collaboration and team roles, and delivered early indicators of success.

The session concluded with guidance on how clinical research professionals could prepare for an AI-driven future—including the skills, mindsets, and change-management readiness needed to support responsible adoption while maintaining participant protections and trial integrity.

Upon completion of this continuing education program, participants should be able to:

  1. Describe how AI is reshaping clinical research workflows and identify where human judgment, ethical safeguards, and regulatory expectations remain essential.
  2. Summarize key insights from an AI‑enabled trial‑matching case study to understand how AI can influence collaboration, site activation models, and early indicators of operational success.
  3. Identify the skills, mindsets, and organizational practices clinical research professionals need to prepare for responsible, effective use of AI in research settings.

Speakers:

  • Noelle Gaskill, MBA, ACRP-CP, Vice President, GM Tempus TIME Network, Tempus AI
  • Jennifer Sheller, MPH, ACRP-CP, Senior Vice President and Head, Global Clinical Trial Operations (GCTO), Merck
  • Susan P. Landis, Chief Executive Officer, ACRP (Moderator)

Approved for 1.0 ACRP Contact Hours